191 related articles for article (PubMed ID: 30841447)
21. Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
Xu J; Zhou Y; Yang J; Gu Y; Zhang E; Yuan W; Wang C; Jin G; Ma H; Hu Z
Gene; 2022 Mar; 813():146115. PubMed ID: 34902508
[TBL] [Abstract][Full Text] [Related]
22. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
24. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
25. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
26. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
27. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
Li T; Chen X; Gu M; Deng A; Qian C
Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
[TBL] [Abstract][Full Text] [Related]
28. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Dai DQ
Pathol Res Pract; 2019 May; 215(5):893-899. PubMed ID: 30718100
[TBL] [Abstract][Full Text] [Related]
29. A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification.
Gao Y; Wu C; Huang J; Huang Z; Jin Z; Guo S; Tao X; Lu S; Zhang J; Zhang F; Zhai Y; Shi R; Ye P; Wu J
Comput Biol Med; 2023 Nov; 166():107562. PubMed ID: 37847945
[TBL] [Abstract][Full Text] [Related]
30. Identification of specific modules and hub genes associated with the progression of gastric cancer.
Gong C; Hu Y; Zhou M; Yao M; Ning Z; Wang Z; Ren J
Carcinogenesis; 2019 Oct; 40(10):1269-1277. PubMed ID: 30805585
[TBL] [Abstract][Full Text] [Related]
31. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
32. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer.
Cheng J; Zhuo H; Xu M; Wang L; Xu H; Peng J; Hou J; Lin L; Cai J
J Transl Med; 2018 Aug; 16(1):216. PubMed ID: 30068360
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
[TBL] [Abstract][Full Text] [Related]
34. Identification of early diagnostic biomarkers via WGCNA in gastric cancer.
Rezaei Z; Ranjbaran J; Safarpour H; Nomiri S; Salmani F; Chamani E; Larki P; Brunetti O; Silvestris N; Tavakoli T
Biomed Pharmacother; 2022 Jan; 145():112477. PubMed ID: 34864309
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
36. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
37. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract][Full Text] [Related]
38. Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
Liu AG; Zhong JC; Chen G; He RQ; He YQ; Ma J; Yang LH; Wu XJ; Huang JT; Li JJ; Mo WJ; Qin XG
Int J Oncol; 2020 Jul; 57(1):122-138. PubMed ID: 32319600
[TBL] [Abstract][Full Text] [Related]
39. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
40. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
